Additionally, there was evidence that surface ENO1 was shown to exert its previously mentioned non-glycolytic effects to induce pericellular plasminogen activation, promote extracellular matrix degradation and increase invasion and metastasis of tumor cells [43]. The gene discussed is ENO1; the disease is neoplasm.